Interleukin-6 levels in synovial fluids of patients with rheumatoid arthritis correlated with the infiltration of inflammatory cells in synovial membrane

Rheumatology International

Volumn 26, Issue 12, 2006, Pages 1096-1100

  Matsumoto, Tomoko ^a   Tsurumoto, Toshiyuki ^a   Shindo, Hiroyuki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Interleukin 6; Rheumatoid arthritis; Synovial fluid; Synovial membrane

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; KNEE ARTHROPLASTY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYNOVECTOMY; SYNOVIAL FLUID; SYNOVIUM;

ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 33749008494     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-006-0143-2     Document Type: Article

References (18)

1. Desgeorges A, Gabay C, Silacci P, Novick D, Roux-Lombard P, rau G, Dayer JM, Vischer T, Guerne PA (1997) Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid. J Rheumatol 24(8):1510-1516
2. Neidel J, Schulze M, Lindschau J (1995) Association between degree of bone-erosion and synovial fluid-levels of tumor necrosis factor alpha in the knee-joints of patients with rheumatoid arthritis. Inflamm Res 44:217-221
3. Yano K, Nakagawa N, Yasuda H, Tsuda E, Higashio K (2001) Synovial cells from patients with rheumatoid arthritis produce osteoclastgenesis inhibitory factor/osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factor. J Bone Miner Metab 19:365-372
4. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS (1988) The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
5. Tak PP, van der Lubbe PA, Cauli A, Daha MR, Smeets TJ, Kluin PM, Meinders AE, Yanni G, Panayi GS, Breedveld FC (1995) Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 38:1457-1465
6. Tak PP, Smeets TJ, Daha MR, Kluin PM, Meijers KA, Brand R, Meinders AE, Breedveld FC (1997). Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 40:217-225
7. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, Chwiecko J (2002) Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis 61:804-809
8. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Chwiecko J. (2002) Serum matrix metalloproteinases in different histological variants of rheumatoid synovitis. Rheumatology 41:78-87
9. Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, Chwiecko J (2003) Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis. Clin Exp Rheumatol 21:63-69
10. Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A, Kunaver M, Zenz P, Smolen JS (1999) Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology 38:202-213
11. Van Damme J, Schaafsma MR, Conings R, Lenaerts JP, Put W, Billiau A, Fibbe WE (1989) Interleukin 1 induces different cytokines in human fibroblasts. Lymphokine Res 8:282-292
12. Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M (1988) Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18:1797-1801
13. Taga T, Kishimoto T (1997) GP130 and the interleukin-6 family of cytokine. Annu Rev Immunol l15:797-819
14. Choy EH, Isenberg DA, Garrood T, Farrow S, Ioannou Y, Bird H, Cheung N, Williams B, Hazleman B, Price R, Yoshizaki K, Nishimoto N, Kishimoto T, Panayi GS (2002) Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis. A randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum 46:3143-3150
15. Sack U, Kinne RW, Marx T, Heppt P, Bender S, Emmrich (1993) FInterleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis. Rheumatol Int 13:45-51
16. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N (1994) Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152:4149-4156
17. Paleolog EM, Young S, Stark AC, McCloskey RV Feldmann M, Maini RN 1998 Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor-a and interleukin-1 in rheumatoid arthritis. Arthritis Rheum 41(7):1258-1265
18. Moore BA, Aznavoorian S, Engler JA, Windsor LJ (2000) Induction of collagenase-3 (MMP-13) in rheumatoid arthritis synovial fibroblasts. Biochim Biophys Acta 1502(2):307-318